Problem: Treating illness is expensive. In America, annual healthcare expenditures are well into the trillions, and around 75% of the treated illnesses are chronic yet should be preventable/manageable. Additionally, people are living longer but not necessarily better, especially in the last quarter of life.
Technology: A body chemistry sensor called Lumee from Profusa constantly monitors localized tissue activity, specifically recording data on glucose and oxygen levels. Closely monitoring these metrics, could prevent diabetic patients who experience neuropathy from requiring amputations. Furthermore, as the technology becomes more advanced, the hope is that it will be able to detect if the body is out of homeostasis for any reason, with the intent of diagnosing other diseases at the onset.
- Citizens of the world
- Medical community
- Governments that want to simultaneously improve public health and reduce medical costs
Implementation: I think a great way to kick this off would be to institute a pilot with diabetic patients who have a particularly difficult time managing their insulin and/or patients who are experiencing consistent complications with diabetic neuropathy. If successful health insurance companies could either subsidize the cost for patients, or incentivize hospitals and medical practices to offer the technology.